Stomach cancer rate set to fall further 25 percent over next decade

New cases of stomach cancer are set to plummet a further 25 per cent in the West over the next decade, indicates research published ahead of print in the journal Gut.

Stomach cancer is the fourth most common cancer, and the second leading cause of cancer related death, in the world.

The findings are based on the long term monitoring of the three types of cell changes indicative of subsequent stomach cancer.

The authors tracked all new cases of atrophic gastritis, intestinal metaplasia, and dysplasia recorded in the Dutch national registry of diseased tissue samples.

The monitoring period covered the years 1991 to 2005 and included almost 98,000 patients who had a routine tissue sample (biopsy) taken.

Most of the cases were intestinal metaplasia, which was diagnosed in almost 66,000 patients during the monitoring period.

The figures showed that the rate of new cases fell steadily by between 2.4 and 2.9% a year in women and men, respectively.

Dysplasia, which was diagnosed in just over 8500 patients, and atrophic gastritis, which was diagnosed in just over 23,000, both fell by more than 8% a year.

The fall in new cases of intestinal metaplasia and atrophic gastritis was even sharper after 1996, the figures showed.

On the basis of these trends, the authors calculate that new cases of gastric cancer will fall by at least 24% over the next decade in the West, without the need for treatment.

The authors say that the fall in the number of cases of gastric inflammation caused by Helicobacter pylori infection largely explains the figures.


Contact: Emma Dickinson
BMJ-British Medical Journal

Page: 1

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
6. Pathway links inflammation, angiogenesis and breast cancer
7. Using MRI for diagnosis could help prevent breast cancer progression
8. Electric fields have potential as a cancer treatment
9. Shining light on pancreatic cancer
10. Method shows promise for early detection of pancreatic cancer
11. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer

Post Your Comments:

(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... the latest in wound care advancements to physician colleagues, skilled nursing facility medical ... titled, "Navigating the Treacherous Waters of Wound Care." , "At many of these ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)...  As the latest Obamacare repeal effort moves is ... (R-LA) and Lindsey Graham (R-SC) medical device ... industry is in an odd place.  The industry wants ... tax on medical device sales passed along with the ... increased visits and hospital customers with the funding to ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/18/2017)... ALLENTOWN , Pa. and KALAMAZOO, Mich. ... Allentown, Penn. , and OptiMed Specialty Pharmacy ... a business partnership to offer a strategic hub service ... PMD Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, ... A spirometer is a medical device used ...
Breaking Medicine Technology:
Cached News: